Canadian Journal of Gastroenterology (Jan 2010)

Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures

  • Mevlut Kurt,
  • Ibrahim Koral Onal,
  • Meral Akdogan,
  • Murat Kekilli,
  • Mehmet Arhan,
  • Abdurrahim Sayilir,
  • Erkin Oztas,
  • Ibrahim Celalettin Haznedaroglu

DOI
https://doi.org/10.1155/2010/896819
Journal volume & issue
Vol. 24, no. 6
pp. 380 – 384

Abstract

Read online

OBJECTIVE: To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures.